SC 13G Filing

Company

Kiniksa Pharmaceuticals International, plc

Filed

May 31, 2018

Accession Number

0001193805-18-000776

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →